Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
60.17
-0.47 (-0.78%)
At close: Oct 7, 2025, 4:00 PM EDT
60.00
-0.17 (-0.28%)
After-hours: Oct 7, 2025, 6:43 PM EDT
Cytokinetics Employees
Cytokinetics had 498 employees as of December 31, 2024. The number of employees increased by 75 or 17.73% compared to the previous year.
Employees
498
Change (1Y)
75
Growth (1Y)
17.73%
Revenue / Employee
$172,165
Profits / Employee
-$1,217,492
Market Cap
7.20B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 498 | 75 | 17.73% |
| Dec 31, 2023 | 423 | 14 | 3.42% |
| Dec 31, 2022 | 409 | 156 | 61.66% |
| Dec 31, 2021 | 253 | 69 | 37.50% |
| Dec 31, 2020 | 184 | 28 | 17.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CYTK News
- 11 hours ago - CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm - PRNewsWire
- 1 day ago - CYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - GlobeNewsWire
- 7 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics - GlobeNewsWire
- 8 days ago - Shareholders who lost money in shares of Cytokinetics, Incorporated (NASDAQ: CYTK) Should Contact Wolf Haldenstein Immediately Lead Plaintiff Deadline is November 17, 2025 - GlobeNewsWire
- 8 days ago - Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025 - GlobeNewsWire
- 12 days ago - Shareholders who lost money in shares of Cytokinetics, Incorporated (NASDAQ: CYTK) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 13 days ago - Cytokinetics Announces Call for Proposals for Its Eighth Annual Communications Grant Program - GlobeNewsWire
- 14 days ago - Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum - GlobeNewsWire